BenevolentAI
BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.
HQ location
London, United Kingdom
Website
Launch date
Employees
Market cap
$13.0m
- B2B
- manufacturing
- commission
- health
- pharmaceutical
- biotechnology
- artificial intelligence
- deep tech
- machine learning
- biotechnology
- sustainable development goals
- dt and ls
- core ai
- ai applications
- verified unicorns and $1b exits
- drug development
- nif defense security and resilience
- ai drug discovery
- techbio
- tech for biotech and pharma
- startup luxembourg
- digital pharma
- techbio drug discovery
- spac ipo announced
- spac target
- nif health crisis preparedness
- from $1b exit to zebra
- techscale200
- compbio
- nif biotech
- bia techbio uk
Authorizing premium user...